$us1.4 billion relenza sales From Wallstreet Journal last night.
Nomura Securities upgraded British pharmaceutical giant GlaxoSmithKline to "buy" from "neutral". Nomura said the Company will reap an extra $1.4 billion of revenue from its Relenza flu treatment. Glaxo shares added 1% in London.
What does that do to everyones outlook on BTA.
- Forums
- ASX - By Stock
- BTA
- anticipate a fall today...
anticipate a fall today..., page-3
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online